Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Glioma | Q9NZM4 | map05214 | carbimazole | 31072 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | carbimazole | 31072 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | carbimazole | 31072 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | carbimazole | 31072 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | carbimazole | 31072 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | carbimazole | 31072 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | carbimazole | 31072 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | colecalciferol | 5280795 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | colecalciferol | 5280795 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | colecalciferol | 5280795 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | niridazole | 3396 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | niridazole | 3396 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | niridazole | 3396 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | niridazole | 3396 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | niridazole | 3396 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | niridazole | 3396 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | niridazole | 3396 | drug-path |
Gap junction | R-HSA-190861 | map04540 | pilocarpine | 5910 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | pilocarpine | 5910 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | neostigmine bromide | 8246 | drug-path |